Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy

被引:30
作者
Burgio, Marco Dioguardi [1 ]
Ronot, Maxime [1 ,2 ]
Salvaggio, Giuseppe [3 ]
Vilgrain, Valerie [1 ,2 ]
Brancatelli, Giuseppe [3 ]
机构
[1] Univ Hosp Paris Nord Val de Seine, Beaujon Hosp, AP HP, Dept Radiol, Clichy, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, INSERM UMR 1149, Paris, France
[3] Univ Palermo, Sect Radiol Sci, Dept Biopathol & Med Biotechnol DiBiMed, Palermo, Italy
关键词
GD-EOB-DTPA; CONTRAST-ENHANCED ULTRASOUND; HEPATOCELLULAR ADENOMA; GADOBENATE DIMEGLUMINE; HEPATOBILIARY-PHASE; NATURAL COURSE; LIVER-LESIONS; MRI; CT; DIFFERENTIATION;
D O I
10.1053/j.sult.2016.08.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Focal nodular hyperplasia (FNH) is the second most common benign solid liver lesion after hemangioma, occurring more frequently in young women. The prime differential diagnoses include hepatocellular adenoma, hepatocellular carcinoma, and hypervascular metastasis. As the management of FNH is typically conservative, imaging plays a key role in diagnostic pathway, and misdiagnosis may have a major clinical effect. In this article, we describe the ultrasound, computed tomography, and magnetic resonance imaging features of FNH, underlining the importance of typical radiological features that allow a specific noninvasive diagnosis. We present a large spectrum of a typical imaging findings that FNH may present and discuss the up-to-date diagnostic strategy. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:511 / 524
页数:14
相关论文
共 72 条
  • [21] Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?
    Galia, Massimo
    Taibbi, Adele
    Marin, Daniele
    Furlan, Alessandro
    Burgio, Marco Dioguardi
    Agnello, Francesco
    Cabibbo, Giuseppe
    Van Beers, Bernard E.
    Bartolotta, Tommaso Vincenzo
    Midiri, Massimo
    Lagalla, Roberto
    Brancatelli, Giuseppe
    [J]. DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2014, 20 (03) : 222 - 228
  • [22] Which is the best MRI marker of malignancy for atypical cirrhotic nodules: Hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration
    Golfieri, Rita
    Grazioli, Luigi
    Orlando, Emanuela
    Dormi, Ada
    Lucidi, Vincenzo
    Corcioni, Beniamino
    Dettori, Ernesto
    Romanini, Laura
    Renzulli, Matteo
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2012, 36 (03) : 648 - 657
  • [23] Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: Prospective study
    Grazioli, L
    Morana, G
    Kirchin, MA
    Schneider, G
    [J]. RADIOLOGY, 2005, 236 (01) : 166 - 177
  • [24] Focal nodular hyperplasia: Morphologic and functional information from MR imaging with gadobenate dimeglumine
    Grazioli, L
    Morana, G
    Federle, MP
    Brancatelli, G
    Testoni, M
    Kirchin, MA
    Menni, K
    Olivetti, L
    Nicoli, N
    Procacci, C
    [J]. RADIOLOGY, 2001, 221 (03) : 731 - 739
  • [25] Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid-enhanced MR Imaging in Differential Diagnosis
    Grazioli, Luigi
    Bondioni, Maria Pia
    Haradome, Hiroki
    Motosugi, Utaroh
    Tinti, Rita
    Frittoli, Barbara
    Gambarini, Sebastiana
    Donato, Francesco
    Colagrande, Stefano
    [J]. RADIOLOGY, 2012, 262 (02) : 520 - 529
  • [26] Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound
    Guibal, Aymeric
    Boularan, Camille
    Bruce, Matthew
    Vallin, Melanie
    Pilleul, Frank
    Walter, Thomas
    Scoazec, Jean Yves
    Boublay, Nawele
    Dumortier, Jerome
    Lefort, Thibaut
    [J]. EUROPEAN RADIOLOGY, 2013, 23 (04) : 1138 - 1149
  • [27] Diagnosis of Focal Nodular Hyperplasia With MRI: Multicenter Retrospective Study Comparing Gadobenate Dimeglumine to Gadoxetate Disodium
    Gupta, Rajan T.
    Iseman, Christine M.
    Leyendecker, John R.
    Shyknevsky, Inna
    Merkle, Elmar M.
    Taouli, Bachir
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (01) : 35 - 43
  • [28] PHASE-I CLINICAL-EVALUATION OF GD-EOB-DTPA AS A HEPATOBILIARY MR CONTRAST AGENT - SAFETY, PHARMACOKINETICS, AND MR-IMAGING
    HAMM, B
    STAKS, T
    MUHLER, A
    BOLLOW, M
    TAUPITZ, M
    FRENZEL, T
    WOLF, KJ
    WEINMANN, HJ
    LANGE, L
    [J]. RADIOLOGY, 1995, 195 (03) : 785 - 792
  • [29] Focal nodular hyperplasia: Findings at state-of-the-art MR imaging, US, CT, and pathologic analysis
    Hussain, SM
    Terkivatan, T
    Zondervan, FE
    Lanjouw, EE
    de Rave, S
    Ifzermans, JNM
    [J]. RADIOGRAPHICS, 2004, 24 (01) : 3 - 17
  • [30] Focal nodular hyperplasia: imaging findings
    Kehagias, D
    Moulopoulos, L
    Antoniou, A
    Hatziioannou, A
    Smyrniotis, V
    Trakadas, S
    Lahanis, S
    Vlahos, L
    [J]. EUROPEAN RADIOLOGY, 2001, 11 (02) : 202 - 212